Ba253BINEB

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Ba253BINEB, covering 2014-07-11 to 2014-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Ba253BINEB Compared to Ba253MDI (Metered Dose Inhaler) in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

See pricing